Therefore, in resource‐poor settings, a handheld or portable point‐of‐care testing (POCT) device for Hb and Hct level assessment potentially plays a key role as a tool for anemia detection, improving the problems of delayed diagnosis and interventions that lead to increased morbidity and mortality. This evidence concerns the gene GSTM1 and anemia.